About VIVOGENE
VIVOGENE is a Healthcare company based in Chennai (India) founded in 2017. It operates as a drug discovery and medicinal chemistry services are offered. VIVOGENE offers products and services including Human stem cell derived supplements, Plant stem cell derived supplements, Rapid skin ECM, I-AAHD, and Bioinformatics Services. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified. Its legal entity in India is Vivogene Life Sciences Llp (AAY-0331). Similar companies include Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group and 5 more; 8 of its 10 listed similar companies have raised funding.
Company details
VIVOGENE was founded in 2017 and is based in Chennai, India. Operations focus on the biotechnology sector, with services encompassing custom synthesis of complex molecules, comprehensive literature searches, early-stage drug discovery, custom library synthesis, development of custom building blocks, novel route design, and contract research for stem cell therapies. These activities support pharmaceutical research and development needs.
- Headquarters Chennai, India
- SectorsHealthcare
- Email••••••••
- Website vivogene.net
- Legal Name Vivogene Life Sciences Llp
- Date of Incorporation 03 Aug, 2021
- Jurisdiction Chennai, Tamil Nadu, India
Associated legal entities of VIVOGENE
VIVOGENE operates through Vivogene Life Sciences Llp (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Vivogene Life Sciences Llp CIN AAY-0331 | Active | 03 Aug 2021 | Chennai, Tamil Nadu | – | – | 2 | View details |
Products & Services of VIVOGENE
VIVOGENE offers a comprehensive portfolio of products and services, including Human stem cell derived supplements, Plant stem cell derived supplements, Rapid skin ECM, I-AAHD, and Bioinformatics Services.
Supplements from human stem cells for cosmetic procedures.
Supplements from plant stem cells for skin care and antioxidants.
System for administering extra-cellular matrix for injury treatment.
Antimicrobial haemostat device for rapid wound control.
Reagents for molecular biology and immunology applications.
Support for drug discovery and custom molecule synthesis.
Board of directors of Vivogene Life Sciences Llp (VIVOGENE)
Vivogene Life Sciences Llp is the primary company behind VIVOGENE. The board of Vivogene Life Sciences Llp currently have 2 directors; the longest-serving is Ellini Mohan Jyothi, appointed in 2021.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ellini Mohan Jyothi DIN 02703229 | Designated Partner | 03 Aug 2021 | 5 yrs 2 mo | Vivogene Life Sciences Llp |
| Yatish Ellini DIN 08320740 | Designated Partner | 03 Aug 2021 | 5 yrs 2 mo | Vivogene Life Sciences Llp |
Similar companies to VIVOGENE
VIVOGENE has 10 listed similar companies in our database, 8 of them funded. They include Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| univercells.com | 2013 | Charleroi, Belgium | $150.64M | 87 | Biomanufacturing technologies are supplied for biopharma antibody and vaccine production. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| straumann.com | 1954 | Basel, Switzerland | – | – | Dental implants and regenerative dentistry products are developed. | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. | |
| judges.uk.com | 2002 | London, United Kingdom | – | 622 | Acquisition and development of scientific instrument businesses is conducted. | |
| savarapharma.com | 2008 | Austin, United States | $67.82M | 37 | Therapeutics for rare respiratory diseases are developed by Savara Pharma. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. | |
| synthego.com | 2012 | Redwood, United States | $459.75M | – | CRISPR-engineered cell and gene therapies are developed for research applications. |
Detailed similar companies of VIVOGENE
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as VIVOGENE (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about VIVOGENE
VIVOGENE was founded in 2017.
VIVOGENE is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
VIVOGENE was founded in 2017 and is based in Chennai, India. Operations focus on the biotechnology sector, with services encompassing custom synthesis of complex molecules, comprehensive literature searches, early-stage drug discovery, custom library synthesis, development of custom building blocks, novel route design, and contract research for stem cell therapies. These activities support pharmaceutical research and development needs.
VIVOGENE's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
VIVOGENE offers Human stem cell derived supplements, Plant stem cell derived supplements, Rapid skin ECM, I-AAHD, and 2 more products and services.
VIVOGENE operates through Vivogene Life Sciences Llp.
The legal entities of VIVOGENE currently have 2 directors, including Ellini Mohan Jyothi, Yatish Ellini.